Literature DB >> 10652273

A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.

M Bitzer1, G von Gersdorff, D Liang, A Dominguez-Rosales, A A Beg, M Rojkind, E P Böttinger.   

Abstract

A number of pathogenic and proinflammatory stimuli, and the transforming growth factor-beta (TGF-beta) exert opposing activities in cellular and immune responses. Here we show that the RelA subunit of nuclear factor kappaB (NF-kappaB/RelA) is necessary for the inhibition of TGF-beta-induced phosphorylation, nuclear translocation, and DNA binding of SMAD signaling complexes by tumor necrosis factor-alpha (TNF-alpha). The antagonism is mediated through up-regulation of Smad7 synthesis and induction of stable associations between ligand-activated TGF-beta receptors and inhibitory Smad7. Down-regulation of endogenous Smad7 by expression of antisense mRNA releases TGF-beta/SMAD-induced transcriptional responses from suppression by cytokine-activated NF-kappaB/RelA. Following stimulation with bacterial lipopolysaccharide (LPS), or the proinflammatory cytokines TNF-alpha and interleukin-1beta (IL-1beta, NF-kappaB/RelA induces Smad7 synthesis through activation of Smad7 gene transcription. These results suggest a mechanism of suppression of TGF-beta/SMAD signaling by opposing stimuli mediated through the activation of inhibitory Smad7 by NF-kappaB/RelA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652273      PMCID: PMC316349     

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  44 in total

1.  Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.

Authors:  M Arsura; M J FitzGerald; N Fausto; G E Sonenshein
Journal:  Cell Growth Differ       Date:  1997-10

Review 2.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.

Authors:  M Grilli; J J Chiu; M J Lenardo
Journal:  Int Rev Cytol       Date:  1993

Review 3.  Cytokine signal transduction.

Authors:  T Kishimoto; T Taga; S Akira
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

Review 4.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

5.  Function of NF-kappa B/Rel binding sites in the major histocompatibility complex class II invariant chain promoter is dependent on cell-specific binding of different NF-kappa B/Rel subunits.

Authors:  A M Brown; M W Linhoff; B Stein; K L Wright; A S Baldwin; P V Basta; J P Ting
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

6.  Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.

Authors:  A G Geiser; J J Letterio; A B Kulkarni; S Karlsson; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Mechanism of activation of the TGF-beta receptor.

Authors:  J L Wrana; L Attisano; R Wieser; F Ventura; J Massagué
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

8.  Overlapping pathways mediate the opposing actions of tumor necrosis factor-alpha and transforming growth factor-beta on alpha 2(I) collagen gene transcription.

Authors:  Y Inagaki; S Truter; S Tanaka; M Di Liberto; F Ramirez
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

9.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

Review 10.  Transforming growth factor beta: the good, the bad, and the ugly.

Authors:  S M Wahl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  152 in total

Review 1.  TGF-beta-mediated control of allergen-specific T-cell responses.

Authors:  Carsten B Schmidt-Weber; Steffen Kunzmann; Kurt Blaser
Journal:  Curr Allergy Asthma Rep       Date:  2002-05       Impact factor: 4.806

2.  TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.

Authors:  C Fiocchi
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 3.  Son of a mother against decapentaplegic.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2003-01       Impact factor: 4.599

4.  Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Authors:  R P Nagarajan; F Chen; W Li; E Vig; M A Harrington; H Nakshatri; Y Chen
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

5.  Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells.

Authors:  Huilin Qi; Dean J Aguiar; Shelly M Williams; Alison La Pean; Wei Pan; Catherine M Verfaillie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

6.  Ecsit is required for Bmp signaling and mesoderm formation during mouse embryogenesis.

Authors:  Changchun Xiao; Jae-hyuck Shim; Michael Klüppel; Samuel Shao-Min Zhang; Chen Dong; Richard A Flavell; Xin-Yuan Fu; Jeffrey L Wrana; Brigid L M Hogan; Sankar Ghosh
Journal:  Genes Dev       Date:  2003-11-21       Impact factor: 11.361

Review 7.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

Review 8.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

9.  NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation.

Authors:  Mikyoung Chang; Andrew J Lee; Leo Fitzpatrick; Minying Zhang; Shao-Cong Sun
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.

Authors:  B Del Zotto; G Mumolo; A M Pronio; C Montesani; R Tersigni; M Boirivant
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.